Patents by Inventor Jiegen CHU

Jiegen CHU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250100973
    Abstract: Provided are a diimide derivative represented by formula I, a preparation method therefor and the use thereof. The diimide derivative has a good anti-tumor activity, and the anti-proliferative activity against various cancer cells is significantly better than those of similar compounds.
    Type: Application
    Filed: January 31, 2023
    Publication date: March 27, 2025
    Applicants: XIANGBEI WELMAN PHARMACEUTICAL CO., LTD., GUANGZHOU CENTURY CLINICAL RESEARCH CO., LTD., GUANGZHOU XIN-CHUANGYI BIOPHARMACEUTICAL CO., LTD., GUANGZHOU XIN CHUANG YI NEW DRUG R&D CO.,LTD, NANJING KANGFUSHUN PHARMACEUTICAL CO., LTD.
    Inventors: Tianyu SUN, Jiegen CHU
  • Publication number: 20230373929
    Abstract: Provided is a fused ring diimide derivative having a chemical structure of formula I. Further provided is a preparation method therefor. The fused ring diimide derivative has excellent anti-tumor activity, and the anti-proliferative activity on various cancer cells is significantly better than that of similar compounds.
    Type: Application
    Filed: September 28, 2021
    Publication date: November 23, 2023
    Applicants: XIANGBEI WELMAN PHARMACEUTICAL CO., LTD., GUANGZHOU XIN-CHUANGYI BIOPHARMACEUTICAL CO., LTD., GUANGZHOU CENTURY CLINICAL RESEARCH CO., LTD., GUANGZHOU XIN CHUANG YI CO., LTD., NANJING KANGFUSHUN PHARMACEUTICAL CO., LTD.
    Inventors: Tianyu SUN, Jiegen CHU